Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04183413
Other study ID # WHO-PEN@Scale
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 1, 2021
Est. completion date December 16, 2022

Study information

Verified date December 2022
Source University Hospital Heidelberg
Contact Till Bärnighausen, MD ScD
Phone +49 6221 56 5637
Email till.baernighausen@uni-heidelberg.de
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The WHO-PEN@Scale project is a three-arm cluster-randomized trial that is investigating the population-level effects of a healthcare reform in Eswatini, which aims to strengthen primary care for diabetes and hypertension. Prior to the reform, healthcare for diabetes and hypertension was mostly provided through physician-led teams in hospital outpatient departments. The healthcare reform aims to strengthen the provision of nurse-led care for diabetes and hypertension in primary healthcare facilities and community health worker-led care for these conditions in the facilities' catchment areas. The reform will broadly be guided by the World Health Organization's "Package of Essential Noncommunicable Disease Interventions for Primary Health Care in Low-Resource Settings" (WHO-PEN). The trial will take place at 84 clusters (a primary healthcare facility and its catchment area) across the country.


Recruitment information / eligibility

Status Recruiting
Enrollment 3500
Est. completion date December 16, 2022
Est. primary completion date December 16, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years and older
Eligibility Inclusion criteria for the outcome assessment (household survey): - Residing in one of the selected households - Age =40 years Exclusion criteria for the outcome assessment (household survey): - Pregnant - Inability to provide written informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
DSD
This intervention consist of three Differentiated Service Delivery Models in which stable clients can be enrolled. The fast-track model gives preferential treatment to enrolled clients. Clients arrive at clinics, usually early in the morning, and can see the nurse as well as collect their medication without queuing. This model mainly targets the working population. The facility-based treatment clubs consist of bimonthly meetings where clients meet in groups of approximately 20 members. They receive health counselling, risk factor screening and medication prescription. This model mainly targets clients living close to the facility. The community advisory groups consist of groups of up to six clients. Groups are equipped with a point of care blood pressure and blood glucose measurement devices. They take turns in collecting the medication for the entire group and meet on a monthly basis. This model targets clients in hard-to-reach areas.
CDP
Community Distribution Points are set up on a monthly basis in communities linked to the clinic. Healthcare staff sets up a temporary point of contact where clients can obtain screening for diabetes and hypertension, health counselling, referral to primary or tertiary facilities, and medication.

Locations

Country Name City State
Swaziland Clinton Health Access Initiative Mbabane

Sponsors (8)

Lead Sponsor Collaborator
University Hospital Heidelberg Amsterdam Institute for Global Health and Development, Clinton Health Access Initiative, Eswatini, Diabetes Swaziland, SWABCHA, Eswatini, Swiss Tropical & Public Health Institute, University of Eswatini, University of Göttingen

Country where clinical trial is conducted

Swaziland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Glycemic control (continuous) among adults with diabetes Mean glycated haemoglobin (HbA1c) among adults aged 40 years and older with diabetes 12 months
Primary Systolic blood pressure among adults with hypertension Mean systolic blood pressure among adults aged 40 years and older with hypertension 12 months
Secondary HbA1c among adults with diabetes or prediabetes Mean glycated haemoglobin (HbA1c) among adults aged 40 years and older with diabetes or prediabetes 12 months
Secondary Glycemic control (binary) among adults with diabetes The proportion of adults aged 40 years and older with diabetes who have an HbA1c less than 7.0% 12 months
Secondary Glycemic control (binary) among adults with diabetes or prediabetes The proportion of adults aged 40 years and older with diabetes or prediabetes who have an HbA1c less than 7.0% 12 months
Secondary Awareness of one's diabetes diagnosis The proportion of adults aged 40 years and older with diabetes who report to have been diagnosed with diabetes prior to the household survey 12 months
Secondary Awareness of one's diabetes or prediabetes diagnosis The proportion of adults aged 40 years and older with diabetes or prediabetes who report to have been diagnosed with diabetes or prediabetes prior to the household survey 12 months
Secondary Probability of being treated for diabetes among adults with diabetes The proportion of adults aged 40 years and older with diabetes who report to be taking medication for their diabetes 12 months
Secondary Probability of having been tested for diabetes among adults with diabetes The proportion of adults aged 40 years and older with diabetes who report to have ever been tested for diabetes 12 months
Secondary Probability of having been tested for diabetes among adults with diabetes or prediabetes The proportion of adults aged 40 years and older with diabetes or prediabetes who report to have ever been tested for diabetes 12 months
Secondary Probability of smoking among adults with diabetes, prediabetes, or hypertension The proportion of adults aged 40 years and older with diabetes, prediabetes, or hypertension who report to be a current smoker 12 months
Secondary Time spent doing moderate- or vigorous-intensity exercise among adults with diabetes, prediabetes, or hypertension The mean number of minutes in a typical week spent doing moderate- or vigorous-intensity exercise among adults aged 40 years and older with diabetes 12 months
Secondary Systolic blood pressure among adults with diabetes Mean systolic blood pressure among adults aged 40 years and older with diabetes 12 months
Secondary Systolic blood pressure among adults with diabetes or prediabetes Mean systolic blood pressure among adults aged 40 years and older with diabetes or prediabetes 12 months
Secondary Diastolic blood pressure among adults with diabetes Mean diastolic blood pressure among adults aged 40 years and older with diabetes 12 months
Secondary Diastolic blood pressure among adults with diabetes or prediabetes Mean diastolic blood pressure among adults aged 40 years and older with diabetes or prediabetes 12 months
Secondary Hypertension control (binary) among adults with hypertension The proportion of adults aged 40 years and older with hypertension who have a systolic blood pressure <140 mm Hg and a diastolic blood pressure <90 mm Hg 12 months
Secondary Diastolic blood pressure among adults with hypertension Mean diastolic blood pressure among adults aged 40 years and older with hypertension 12 months
Secondary Awareness of one's hypertension diagnosis The proportion of adults aged 40 years and older with hypertension who report to have been diagnosed with hypertension prior to the household survey 12 months
Secondary Probability of being treated for hypertension among adults with hypertension The proportion of adults aged 40 years and older with hypertension who report to be taking blood-pressure-lowering medication 12 months
Secondary Probability of having been tested for hypertension among adults with hypertension The proportion of adults aged 40 years and older with hypertension who report to have ever had their blood pressure measured 12 months
Secondary Frequency of drinking alcohol in the past 12 months among adults with diabetes, prediabetes, or hypertension The proportion of adults aged 40 years and older with diabetes, prediabetes, or hypertension who report to having drunk daily, 5-6 days per week, 3-4 days per week, 1-2 days per week, 1-3 days per month, less than once a month, or never over the past 12 months. 12 months
Secondary 21. Knowledge on diabetes and hypertension among adults with diabetes, prediabetes, or hypertension The proportion of adults aged 40 years and older with diabetes, prediabetes, or hypertension who correctly responded to each individual question on diabetes and hypertension related knowledge. 12 months
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A